WASHINGTON (AP) — The Food and Drug Administration said Monday that it has approved broader use of an innovative artificial heart valve that can be implanted without major surgery, allowing surgeons to insert the implant through multiple pathways.
The agency approved revised labeling for Edwards Lifesciences’ Sapien heart valve, which is approved for patients who face major risks from open-heart surgery or who are too sick to have that procedure done.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.